Crane Company (CR) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
Q3 sales rose 28.1% to $754.6M, with 7.7% core growth and 21.1% acquisition contribution; adjusted EPS reached a record $2.05.
Core backlog grew 9% YoY to $1,894.9M; FY2026 adjusted EPS guidance increased to $7.23–$7.38.
Financial highlights
Adjusted operating profit rose 35.8% to $169.9M; adjusted operating margin expanded 130 bps to a record 22.5%.
GAAP operating profit rose 18.8% to $140.6M, while GAAP operating margin declined to 18.6% from 20.1%.
Adjusted diluted EPS was $2.05 versus $1.67; GAAP diluted EPS was $1.66 versus $1.56.
Adjusted EBITDA increased 35.0% to $180.8M, with margin of 23.9% versus 22.7%.
Adjusted free cash flow from continuing operations was $126.4M versus $118.9M in Q3 2025.
Outlook and guidance
FY2026 adjusted EPS guidance rose to $7.23–$7.38 from $6.85–$7.05; adjusted segment operating margin outlook increased to ~24%.
FY2026 revenue guidance increased to $2.886B–$2.922B; core sales growth is expected at the high end of the prior 5%–6% range.
FY sales growth is expected in the mid-20% range, with acquisition contribution and core growth at the high end of prior ranges.
FY2026 corporate expense is expected at $80M–$85M, net non-operating expense at ~$58M and adjusted tax rate at ~23%.
Aerospace & Advanced Technologies expects FY core growth slightly above its 7%–9% long-term framework; Process Flow Technologies expects low-single-digit core growth and continued margin expansion.
Latest events from Crane Company
- Record Q2 sales, margin expansion, and raised EPS guidance driven by strong demand and acquisitions.CR
Q2 2026 - Record adjusted EPS and 24.9% sales growth drove raised full-year guidance and strong M&A capacity.CR
Q1 2026 - Proxy details director elections, auditor ratification, and strong 2024 performance with robust governance.CR
Proxy filing - Annual meeting to vote on directors, auditor, and pay, with online and eco-friendly options.CR
Proxy filing - Record 2025 EPS growth, robust M&A, and 10% EPS growth guidance for 2026.CR
Q4 2025 - Adjusted EPS up 27% on strong sales; guidance raised and PSI acquisition progressing.CR
Q3 2025 - Q2 sales up 9.2%, EPS up 24%, guidance raised, and $1.06–$1.15B PSI acquisition announced.CR
Q2 2025 - Q1 2025 delivered strong EPS and sales growth, with robust outlook and active M&A pipeline.CR
Q1 2025 - Q4 adjusted EPS up 58%, 2025 guidance raised, and dividend increased 12%.CR
Q4 2024